CN105456710B - A kind of blood activating and fat reducing medicine and preparation method thereof - Google Patents

A kind of blood activating and fat reducing medicine and preparation method thereof Download PDF

Info

Publication number
CN105456710B
CN105456710B CN201610007752.XA CN201610007752A CN105456710B CN 105456710 B CN105456710 B CN 105456710B CN 201610007752 A CN201610007752 A CN 201610007752A CN 105456710 B CN105456710 B CN 105456710B
Authority
CN
China
Prior art keywords
parts
blood
fat reducing
blood activating
reducing medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610007752.XA
Other languages
Chinese (zh)
Other versions
CN105456710A (en
Inventor
孟寒
杨光清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610007752.XA priority Critical patent/CN105456710B/en
Publication of CN105456710A publication Critical patent/CN105456710A/en
Application granted granted Critical
Publication of CN105456710B publication Critical patent/CN105456710B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/424—Gynostemma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention provides a kind of blood activating and fat reducing medicine, it is related to the field of Chinese medicines.The blood activating and fat reducing medicine is mainly made up of following raw material, counts in parts by weight：10~15 parts of 30~60 parts of the Radix Astragali, 10~15 parts of perillaseed, 10~12 parts of semen brassicae, 10~20 parts of radish seed, 10~20 parts of gynostemma pentaphylla, 10~15 parts of marine alga, 10~15 parts of kelp, 10~25 parts of raw hawthorn, 10~30 parts of the fleece-flower root, 10~20 parts of RHIZOMA POLYGONATI PREPARATA and ganoderma lucidum.Blood activating and fat reducing medicine provided by the invention can eliminating the phlegm dehumidifying, dredging collateral, blood activating and fat reducing, can effectively treat the disease such as cardiovascular and cerebrovascular disease and hypertension, high fat of blood, diabetes, gout, good effect is practical.Present invention also offers a kind of preparation method of above-mentioned blood activating and fat reducing medicine, this method is simple to operate, and it is convenient to prepare.

Description

A kind of blood activating and fat reducing medicine and preparation method thereof
Technical field
The present invention relates to the field of Chinese medicines, in particular to a kind of blood activating and fat reducing medicine and preparation method thereof.
Background technology
With the raising of today's society living standard, rhythm of life is accelerated, and dietary structure changes, and physical exertion is progressively Ascendant trend year by year is all presented in the influence of the factors such as reduction, many diseases of the mankind, such as：Cardiovascular and cerebrovascular disease, hypertension, height Blood fat, diabetes, gout.Doctor trained in Western medicine all takes the method treatment of " suit the medicine to the illness, support " when treating such disease substantially, and what is utilized controls Although treat medicine can obtain certain therapeutic effect in short term, under long-term treatment, with the enhancing of patient's drug resistance with And the appearance of disease complication itself, the therapeutic effects of these medicines is just worse and worse.
The content of the invention
In view of this, the invention provides a kind of blood activating and fat reducing medicine and preparation method thereof, with improve existing medicine for The problem of therapeutic effect of the diseases such as hypertension, high fat of blood is poor.
To achieve the above object, the present invention provides following technical scheme：
A kind of blood activating and fat reducing medicine, is mainly made up of following raw material, counts in parts by weight：30~60 parts of the Radix Astragali, perillaseed 10~ 15 parts, 10~12 parts of semen brassicae, 10~20 parts of radish seed, 10~20 parts of gynostemma pentaphylla, 10~15 parts of marine alga, 10~15 parts of kelp, 10~15 parts of 10~25 parts of raw hawthorn, 10~30 parts of the fleece-flower root, 10~20 parts of RHIZOMA POLYGONATI PREPARATA and ganoderma lucidum.
Relative to prior art, the present invention includes following beneficial effect：For cardiovascular and cerebrovascular disease, hypertension, high blood During the diseases such as fat, diabetes, gout, the traditional Chinese medical science be attributable to " dizziness ", " apoplexy ", " beadache with internal injury ", " chest impediment and cardialgia ", " quenching one's thirst ", Categories such as " rheumatisms ".Morbidity more by disorder of affect, overfeeding delicious food pure wine, it is easy the factor such as enjoy and cause human body phlegm wet, water to be drunk, Caused by stagnation of blood stasis internal organs, meridian qi and blood are obstructed, focus is formed.《Plain Questions is logical to comment actual situation opinion》A piece just has：It is " all to control the illness that disappears, fall forward Hit, be hemiplegia, impotence is fainted, gas is completely sent out inverse, the disease of fertile high official, then fat meat and fine grain " record.《Danxi's experiential therapy apoplexy》There is " wet soil life again Phlegm, phlegm heat, hot air wind producing " is said.
The present invention is exactly according to above-mentioned theory of traditional Chinese medical science, using the method for " eliminating the phlegm dehumidifying, promoting blood circulation and removing blood stasis, calming wind and dredging collateral relieve pain " Carry out dialectical treatmert.Through cloud：" then blood, blood wind go out gas row certainly "；Cloud " control wind and first control phlegm " again；《Records of Tradition Chinese and Western Medicine in Combination》 Cloud：" energy tonifying Qi, and gas can be risen, kind air (i.e. pectoral qi) in the heart of controlling sink ".So the Radix Astragali is reused in composition of raw materials, Radix Astragali taste It is sweet, tepor, returns spleen lung channel；Air making-up and spleen enlivening, activating blood and promoting diuresis eliminating the phlegm dehumidifying, the gas of main row the whole body, is monarch drug in a prescription.The primary chemical of the Radix Astragali Composition is glycoside, polysaccharide, flavones, amino acid, trace element etc., and it can promote organism metabolism, improve anti-fatigue ability, promote blood The renewal of cleer and peaceful hepatic protein, there is obvious diuresis, hypoglycemia can be raised, reduce hyperglycaemia, heart receipts can be strengthened Contracting power, cardiovascular system, anti-arrhythmia, coronary artery dilator and peripheral vascular are protected, is reduced blood pressure, reduce platelet adhesion reaction Power, reduce thrombosis.The Radix Astragali also has obvious reducing blood lipid, anti-aging, anti anoxia, radioresistance and hepatoprotective effect.In raw material The compositions such as perillaseed, semen brassicae are also added into, these compositions mutually cooperate with the Radix Astragali, can strengthen the effect for reducing blood fat of the Radix Astragali, be Ministerial drug.Gynostemma pentaphylla, perillaseed, semen brassicae, radish seed, marine alga, the product that kelp is eliminating the phlegm dehumidifying, can promote the Radix Astragali to play effectiveness, Strengthen the property of medicine effect of blood activating and fat reducing medicine.Modern pharmacological research confirms that gynostemma pentaphylla is containing a variety of saponin(es, carbohydrate, flavonoids, vitamin C and 18 kinds of amino acid and a variety of inorganic elements etc., gynostemma pentaphylla and gypenoside be respectively provided with antifatigue, anti anoxia, high temperature resistance, The characteristics of low-temperature resistance, biological cell and drosophila, the life-span of mouse can be extended, moreover it is possible to substantially increase nospecific immunity, thin Born of the same parents are immune, the function of humoral immunity, and have obvious hypoglycemic, effect for reducing blood fat；And the perilla herb oil that perillaseed extracts has substantially Effect for reducing blood fat, can extend its survival rate to the spontaneous hypertensive rat feeding perilla herb oil for being easy to palsy, make life span Extend；Semen brassicae and radish seed have antibacterial, eliminating the phlegm, antibechic, the characteristics of relievining asthma, and can improve urinary function, reduce cholesterol, prevent Only artery sclerosis, the extract solution of radish seed, which also has, to be relaxed and lasting antihypertensive effect；Marine alga and kelp contain iodide, to lacking Endemicgoiter has greatly therapeutic action caused by iodine, in addition, the alginic acid sulfuric acid ester contained in marine alga, kelp has anti-high blood Fat acts on, and can reduce serum cholesterol and mitigate atherosclerosis, its preserved material also has antihypertensive effect；Raw hawthorn primary chemical into It is divided into triterpene saponin, aliphatic acid, vitamin C, its energy platelet aggregation-against, moreover it is possible to reduce the cholesterol and glycerine three in serum Ester, it is dense by improving serum middle-high density cholesterol and its subfraction that it, which reduces serum cholesterol and the effect of triglycerides, Degree, increases the excretion of cholesterol and realizes；And to be nourishing yin and nourishing blood promote the production of body fluid medicine for the fleece-flower root, RHIZOMA POLYGONATI PREPARATA and ganoderma lucidum, there is increase hat Arteries and veins flow and the effect of decompression, blood fat can be reduced, mitigate Coronary Artery Atherosclerosis, it is too high to blood glucose caused by adrenal gland Also it is in significant inhibitory action, also has and suppress adrenocortical effect and the effect of anti-aging.Reason caused by gout One of be due to Hyperlipemia, blood viscousness, metabolism is slow, in vivo caused by uric acid be more than the uric acid of discharge, cause uric acid to exist Caused by heaping in vivo, and said medicine passes through itself reducing blood lipid, the effect of diuresis, so that it may and it is obvious to reduce uric acid in blood content, Effectively treatment gout.
In the present invention, monarch drug in a prescription and ministerial drug cooperate, and play good synergy, are fundamentally played a role from body, Effect a permanent cure rather than take stopgap measures, air making-up and spleen enlivening, blood activating and fat reducing, nurse one's health energy and blood of human body, practicality is high, suitable for large-scale promotion.
Preferably, in above-mentioned blood activating and fat reducing medicine, the raw material also includes 10~12 parts of 10~15 parts of cassia twig and root tuber of aromatic turmeric.Cassia twig Wen Jing activates yang, the promoting flow of qi and blood circulation, is ministerial drug, helps the work(of the Radix Astragali promoting flow of qi and blood circulation.Modern pharmacological research confirms：Cassia twig has diuresis, strong Heart etc. acts on, and root tuber of aromatic turmeric and decoction can reduce WBV, suppress platelet aggregation, and its alcohol extract can reduce plasma fibrin and contain Amount.
Preferably, in above-mentioned blood activating and fat reducing medicine, the raw material also includes 6~10 parts of leech, 10~20 parts of Radix Angelicae Sinensis, ginkgo leaf 10~15 parts, 10~15 parts of Ligusticum wallichii, 10~30 parts of the red sage root, 10~15 parts of turmeric, 10~12 parts of bush, 10~15 parts of decumbent corydalis tuber. These compositions are adjutant, can dredge internal organs, meridian qi and blood.Confirmed according to modern pharmacological research：Hirudin in leech is small to blood Plate is populated with obvious inhibitory action, suppresses thrombosis in rat body, has treatment well to make to disseminated intravascular coagulation With hirudin also has inhibitory action to tumour cell.Radix Angelicae Sinensis, ginkgo leaf, Ligusticum wallichii, the red sage root, turmeric, bush, decumbent corydalis tuber can expand Coronary artery is opened, increases coronary blood flow, improves myocardial ischemia, hypoxia-bearing capability can be improved, microcirculation can be improved, promotes blood stream Speed, blood vessel can be expanded, is reduced blood pressure.
Preferably, in above-mentioned blood activating and fat reducing medicine, the raw material also includes 10~12 parts of earthworm, 10~12 parts of ant powder, stone 10~30 parts of Cassia, 10~15 parts of bluish dogbane, 10~15 parts of the root of fangji.These compositions are adjutant, play and relieve dizziness, high fever, infantile convulsions, epilepsy, etc. in whole medicine The effect removed obstruction in channels to relieve pain.Modern pharmacological research confirms：Earthworm, ant powder have slow and lasting antihypertensive effect, its extract With fibrinolytic and anticoagulation；Acidic extraction liquid shows the clotting assay of rabbit inside and outside in the shell of seaear, and it has significant anti- Solidifying effect；Bluish dogbane, root of fangji decoction have antihypertensive effect, and play the role of stronger diuresis, to reduce blood fat, regulation immune.
Preferably, in above-mentioned blood activating and fat reducing medicine, the raw material also includes 10~30 parts of the root of kudzu vine.Puerarin in the root of kudzu vine can be right Acute myocardial ischemia caused by anti-pituitrin；Pueraria Flavonid can expand coronary artery blood vessel and cerebrovascular increase coronary blood flow And cerebral blood flow (CBF), reduce heart oxygen demand, increase oxygen supply.
Preferably, in above-mentioned blood activating and fat reducing medicine, the raw material also includes 6~10 parts of radix glycyrrhizae.Radix glycyrrhizae can reconcile to make medicine All medicines.Modern pharmacological research confirms：Radix glycyrrhizae has antiarrhythmic effect, and also antidiuresis, lipid-loweringing, liver protection etc. acts on.
Present invention also offers a kind of preparation method of above-mentioned blood activating and fat reducing medicine, according to formula, all raw materials is mixed and ground Mill, is made powder.
Material composition grinding be can be made into powder, taken for patient, it is simple to operate, easy to make.Obtained promoting blood circulation drop The therapeutic effect of fat medicine might as well.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, the method for the mixed grinding is：All raw materials are mixed Close, be ground to particle diameter to be more than 80 mesh.The requirement of the particle diameter is that the consideration of assimilation effect is taken based on human body, while is also met 《Chinese Pharmacopoeia》Regulation.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, the environmental condition of the grinding is：Humidity index is less than 30%.In the preparation process of the medicine, the requirement to environment is considerably less.In this way, by the medicinal application in industrialized production, its into This is relatively low；And personally for, after can also buying raw material, oneself makes and taken, easy to operate.For ambient humidity It is required that effectively can avoid in process of lapping, air humidity is excessive and causes raw mill into paste.
Preferably, in the preparation method of above-mentioned blood activating and fat reducing medicine, before the raw material mixed grinding, in addition to pre- place Reason：The raw material is cleaned, dried.Pretreatment can obtain raw material clean, that water content is considerably less, in this way, advantageously in Raw material powder.
In the present invention, during mixed grinding, it is desirable to carried out under pollution-free, clean and tidy environment.
Whole powder of powder can cross No. five sieves (80 mesh), and 95% fine powder can cross No. six sieves (100 mesh).
The instructions of taking of the blood activating and fat reducing medicine of powder is：Three times a day, taken in meal the latter hour, every time 6~10g, Taken with warm water or white wine, it is a course for the treatment of continuously to take January.
Clinically symptoms include：" vertigo, distending pain in the head, flushing, disposition agitation, dry throat and mouth, palpitaition, discomfort uncomfortable in chest, four limbs Apathy, swelling pain, cusalgia, tongue nature are livid purple, tongue is greasy, wiry and rolling pulse " person, using blood activating and fat reducing medicine provided by the invention Treated.
Doctor trained in Western medicine is diagnosed as：Cerebral infarction or cerebral blood supply insufficiency, heart blood supply insufficiency, hypertension, high fat of blood, diabetes, gout etc. Disease, belong to " blood-stasis internal-depression, phlegm wet hinder network person " through differential diagnosis in tcm, treated using blood activating and fat reducing medicine provided by the invention, Therapeutic effect is rather good.
Discuss and pharmacological action is analyzed：
Blood activating and fat reducing medicine provided by the invention is to aim at modern to suffer from cerebral infarction or the heart, cerebral blood supply insufficiency, hypertension, height The diseases such as blood fat, diabetes, gout and create.Clinically as long as differential diagnosis in tcm belongs to " blood-stasis internal-depression, phlegm wet resistance network person " Treated using this medicine.Because above-mentioned disease belongs to long-term, intractable chronic disease more, so long-term, continuation medication is needed, in this way, It just can guarantee that and reach expected therapeutic effect.So being dissipated, on ball, cream, pellet form from the traditional Chinese medical science, Chinese medicine tradition, select and dissipated Agent formulation, it is therefore an objective to which being easy to medicine to supply, patient is long-term, effectively absorbs and plays lasting therapeutic action.
Compared with prior art, beneficial effects of the present invention are：
(1) good drug efficacy, the diseases such as cardiovascular and cerebrovascular disease, hypertension, high fat of blood, diabetes, gout can effectively be treated；
(2) it is adjusted at all from body, effects a permanent cure rather than take stopgap measures.
Embodiment
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will Understand, the following example is merely to illustrate the present invention, and is not construed as limiting the scope of the present invention.It is unreceipted specific in embodiment Condition person, the condition suggested according to normal condition or manufacturer are carried out.Agents useful for same or the unreceipted production firm person of instrument, it is The conventional products that can be obtained by commercially available purchase.
Embodiment one
Embodiments of the invention one provide a kind of blood activating and fat reducing medicine, are mainly made up of following raw material, count in parts by weight： 30 parts of the Radix Astragali, 10 parts of perillaseed, 10 parts of semen brassicae, 10 parts of radish seed, 10 parts of gynostemma pentaphylla, 10 parts of marine alga, 10 parts of kelp, raw hawthorn 10 Part, 10 parts of the fleece-flower root, 10 parts of RHIZOMA POLYGONATI PREPARATA and 10 parts of ganoderma lucidum.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, and according to formula, all raw materials are mixed It is 80 mesh to be ground to particle diameter, and powder is made.
The instructions of taking of blood activating and fat reducing medicine for the powder preparation formulation that the present embodiment provides is：Daily three times, in postprandial one Individual hour takes, and each 6g, is taken with white wine.
Embodiment two
Embodiments of the invention two provide a kind of blood activating and fat reducing medicine, are mainly made up of following raw material, count in parts by weight： 60 parts of the Radix Astragali, 15 parts of perillaseed, 12 parts of semen brassicae, 20 parts of radish seed, 20 parts of gynostemma pentaphylla, 15 parts of marine alga, 15 parts of kelp, raw hawthorn 25 Part, 30 parts of the fleece-flower root, 20 parts of RHIZOMA POLYGONATI PREPARATA, 15 parts of ganoderma lucidum, 15 parts of cassia twig, 12 parts of root tuber of aromatic turmeric, 10 parts of leech, 20 parts of Radix Angelicae Sinensis, ginkgo leaf 15 parts, 15 parts of Ligusticum wallichii, 30 parts of the red sage root, 15 parts of turmeric, 12 parts of bush, 15 parts of decumbent corydalis tuber.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps：
A. all raw materials are put into pot, add water, the volume of water accounts for the 65% of pot internal volume；
B. pot is heated, decoct raw medicinal material, after in pot solution boiling after decoct 1.5h, then filter, pour out it is pan-fried Boil liquid；
Again toward in pot plus water, the volume of water account for the 50% of pot internal volume, continue to decoct 0.5h after solution boiling in pot, Filter, pour out decoction liquor, the decoction liquor poured out twice is mixed, obtain mixing decoction liquor；
C. mixing decoction liquor is dried, and the mixture after drying is crushed to 100 mesh, be then mixed into cornstarch, press Chinese medicinal tablet is made in piece.
Chinese medicinal tablet made from this law is taken, taken three times a day, each 10g, Ying Shui are swallowed.
Embodiment three
Embodiments of the invention three provide a kind of blood activating and fat reducing medicine, are mainly made up of following raw material, count in parts by weight： 38 parts of the Radix Astragali, 12 parts of perillaseed, 11 parts of semen brassicae, 14 parts of radish seed, 14 parts of gynostemma pentaphylla, 12 parts of marine alga, 12 parts of kelp, raw hawthorn 17 Part, 19 parts of the fleece-flower root, 15 parts of RHIZOMA POLYGONATI PREPARATA, 12 parts of ganoderma lucidum, 10 parts of cassia twig, 10 parts of root tuber of aromatic turmeric, 6 parts of leech, 10 parts of Radix Angelicae Sinensis, ginkgo leaf 10 6 parts of part, 10 parts of Ligusticum wallichii, 10 parts of the red sage root, 10 parts of turmeric, 10 parts of bush, 10 parts of decumbent corydalis tuber and radix glycyrrhizae.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps：
A. raw material is all cleaned, dried；
B. raw material is mixed, is ground under conditions of being 30% in room temperature, humidity index, make the powder that grinding obtains all No. five sieves can be crossed, and 95% fine powder can cross No. six sieves, and powder is made.
Powder made from this law is taken, three times a day, takes, each 7g, is taken with warm water in meal the latter hour.
Example IV
Embodiments of the invention four provide a kind of blood activating and fat reducing medicine, are mainly made up of following raw material, count in parts by weight： 45 parts of the Radix Astragali, 12 parts of perillaseed, 11 parts of semen brassicae, 15 parts of radish seed, 15 parts of gynostemma pentaphylla, 13 parts of marine alga, 13 parts of kelp, raw hawthorn 18 Part, 20 parts of the fleece-flower root, 15 parts of RHIZOMA POLYGONATI PREPARATA, 12.5 parts of ganoderma lucidum, 12 parts of cassia twig, 11 parts of root tuber of aromatic turmeric, 8 parts of leech, 15 parts of Radix Angelicae Sinensis, ginkgo leaf 13.5 parts, 12.5 parts of Ligusticum wallichii, 20 parts of the red sage root, 12 parts of turmeric, 11 parts of bush, 13 parts of decumbent corydalis tuber, 11 parts of earthworm, 11 parts of ant powder, 7.5 parts of 20 parts of the shell of seaear, 13 parts of bluish dogbane, 13 parts of the root of fangji, 20 parts of the root of kudzu vine and radix glycyrrhizae.
The present embodiment additionally provides a kind of preparation method of above-mentioned blood activating and fat reducing medicine, comprises the following steps：
A. raw material is all cleaned, dried；
B. raw material is mixed, in clean, clean and tidy environment, grinds, make under conditions of being 30% in room temperature, humidity index No. five sieves can all be crossed by grinding obtained powder, and 95% fine powder can cross No. six sieves, and powder is made.
Powder made from this law is taken, three times a day, takes, each 8g, is taken with warm water in meal the latter hour.
The guiding theory of this medicine is：Based on the traditional Chinese medical science " organic conception ", " dialectical treatmert ", make in conjunction with modern pharmacology For researching and developing, although full presciption medicine taste is on the high side, more without miscellaneous, medicine in Fang Zhongjun, minister, help, make apparent, Each performs its own functions, jointly Synthesize eliminating the phlegm dehumidifying, effect promoting blood circulation and removing blood stasis, calming wind and dredging collateral analgesic.Blood activating and fat reducing medicine by researcher's many decades clinical practice and The clinical observation on the therapeutic effect of hundreds of patients, it is in treatment cerebral infarction or cerebral blood supply insufficiency, heart blood supply insufficiency, hypertension, high fat of blood, It is evident in efficacy in the diseases such as diabetes, gout.
The blood activating and fat reducing medicine that the present embodiment provides also recorded clinical trial.Using blood activating and fat reducing medicine treatment high fat of blood, In the clinical practice of hypertension and cardiovascular and cerebrovascular diseases, 50 cases are respectively selected more generally to tie up letter system by Beijing Beijing University with using at present " blood fat recovery capsule " of medicine Co., Ltd production is made comparisons analysis, the results showed that what the blood activating and fat reducing medicine that the present embodiment provides was treated Each item data is superior to " blood fat recovery capsule ", is now summarized as follows：
Blood fat recovery capsule basic situation：
Composition：Red yeast rice
Major function：Promoting blood circulation and removing blood stasis, reinforcing spleen to promote digestion.The hyperlipidemia caused by blood stasis, symptoms include shortness of breath and fatigue, head are hindered for phlegm Dizzy headache, abdominal distension uncomfortable in chest, deficiency of food are indigestion and loss of appetite, it can also be used to other cardiovascular and cerebrovascular diseases caused by hyperlipidemia and atherosclerosis Auxiliary treatment.
[execution standard]《Chinese Pharmacopoeia》The enlarged edition of version second in 2010
[authentication code] Chinese medicines quasi-word Z10950029
Efficacy result：
(1) hyperlipemia is treated：
Blood activating and fat reducing dissipates cures in 50 cases：30；It is effective：8；Take a turn for the better：10；It is invalid：2.
Cured in 50 cases of blood fat recovery capsule：10；It is effective：15；Take a turn for the better：18；It is invalid：7.
(2) hypertension is treated：
Blood activating and fat reducing dissipates cures in 50 cases：12；It is effective：28；Take a turn for the better：6；It is invalid：4.
Cured in 50 cases of blood fat recovery capsule：5；It is effective：12；Take a turn for the better：17；It is invalid：16.
(3) cerebral infarction is treated：
Blood activating and fat reducing dissipates cures in 50 cases：8；It is effective：28；Take a turn for the better：10；It is invalid：4.
Cured in 50 cases of blood fat recovery capsule：2；It is effective：12；Take a turn for the better：15；It is invalid：21.
Efficacy analysis：
Blood fat recovery capsule prescription is single, only has certain therapeutic effect to hyperlipidemia, in addition for caused by high fat of blood Atherosclerosis, cranial vascular disease may also have certain auxiliary therapeutic action.And the blood activating and fat reducing that the present embodiment provides It is most that medicine focuses on " high fat of blood " of emphasizing modern medical diagnosis, " hypertension " and other cardiovascular and cerebrovascular diseases on prescription All caused by " phlegm wet ", " water drink " " hemostasis ".Dispelled so combining modern pharmacological research analysis on traditional Chinese medical science Selection drug and having selected Phlegm dehumidifying, phlegm reduction of blood circulation promoting, the product of calming wind and dredging collateral analgesic, make traditional Chinese medical science organic conception and the guideline of dialectical treatmert true in full side Just emerge from, by clinical practice Ureteral Calculus for many years, achieve very satisfied therapeutic effect.
To sum up, the blood activating and fat reducing medicine that the present embodiment provides can effectively treat cardiovascular and cerebrovascular disease and apoplexy, facial paralysis, height The diseases such as blood pressure, high fat of blood, diabetes, gout, practicality is high, and therapeutic effect is good.
In addition, the blood activating and fat reducing medicine that other embodiments are provided is used for cardiovascular and cerebrovascular disease and apoplexy, facial paralysis, treatment height The diseases such as blood pressure, high fat of blood, diabetes, gout, the effect of acquisition are consistent with above-mentioned result of the test.
The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention, for the skill of this area For art personnel, the present invention can have various modifications and variations.Within the spirit and principles of the invention, that is made any repaiies Change, equivalent substitution, improvement etc., should be included in the scope of the protection.

Claims (7)

1. a kind of blood activating and fat reducing medicine, it is characterised in that be mainly made up of following raw material, count in parts by weight：30~60 parts of the Radix Astragali, 10~15 parts of perillaseed, 10~12 parts of semen brassicae, 10~20 parts of radish seed, 10~20 parts of gynostemma pentaphylla, 10~15 parts of marine alga, kelp 10 ~15 parts, 10~25 parts of raw hawthorn, 10~30 parts of the fleece-flower root, 10~20 parts of RHIZOMA POLYGONATI PREPARATA and 10~15 parts of ganoderma lucidum, leech 6~10 Part, 10~20 parts of Radix Angelicae Sinensis, 10~15 parts of ginkgo leaf, 10~15 parts of Ligusticum wallichii, 10~30 parts of the red sage root, 10~15 parts of turmeric, bush 10 ~12 parts, 10~15 parts of decumbent corydalis tuber, 10~15 parts of cassia twig, 10~12 parts of root tuber of aromatic turmeric, 10~12 parts of earthworm, 10~12 parts of ant powder, 10~15 parts of 10~30 parts of the shell of seaear, 10~15 parts of bluish dogbane and the root of fangji.
2. blood activating and fat reducing medicine according to claim 1, it is characterised in that the raw material also includes 10~30 parts of the root of kudzu vine.
3. blood activating and fat reducing medicine according to claim 1, it is characterised in that the raw material also includes 6~10 parts of radix glycyrrhizae.
4. the preparation method of the blood activating and fat reducing medicine described in a kind of any one of claims 1 to 3, it is characterised in that, will according to formula All raw material mixed grindings, are made powder.
5. the preparation method of blood activating and fat reducing medicine according to claim 4, it is characterised in that the method for the mixed grinding For：All raw materials are mixed, are ground to particle diameter to be more than 80 mesh.
6. the preparation method of blood activating and fat reducing medicine according to claim 4, it is characterised in that the environmental condition of the grinding For：Humidity index is less than 30%.
7. the preparation method of blood activating and fat reducing medicine according to claim 4, it is characterised in that the raw material mixed grinding it Before, in addition to pretreatment：The raw material is cleaned, dried.
CN201610007752.XA 2016-01-07 2016-01-07 A kind of blood activating and fat reducing medicine and preparation method thereof Expired - Fee Related CN105456710B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610007752.XA CN105456710B (en) 2016-01-07 2016-01-07 A kind of blood activating and fat reducing medicine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610007752.XA CN105456710B (en) 2016-01-07 2016-01-07 A kind of blood activating and fat reducing medicine and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105456710A CN105456710A (en) 2016-04-06
CN105456710B true CN105456710B (en) 2017-11-21

Family

ID=55595166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610007752.XA Expired - Fee Related CN105456710B (en) 2016-01-07 2016-01-07 A kind of blood activating and fat reducing medicine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105456710B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105999054A (en) * 2016-05-24 2016-10-12 辽宁佰福药业有限公司 Rose diet tea prepared from medical juice and preparation method of rose diet tea
CN107441281A (en) * 2017-08-04 2017-12-08 绿都中草药研发中心（北京）有限公司 A kind of diabetes integrate compound preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101987188B (en) * 2010-11-19 2012-05-30 何明华 Biological Chinese patent drug for preventing and treating hyperlipoidemia
CN102145128B (en) * 2011-03-30 2012-07-11 呼伦贝尔松鹿制药有限公司 Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof
CN102631655B (en) * 2012-04-05 2013-10-30 徐学军 Medicine for treating coronary heart disease and preparation method for medicine

Also Published As

Publication number Publication date
CN105456710A (en) 2016-04-06

Similar Documents

Publication Publication Date Title
CN103053748B (en) Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof
CN103656557B (en) Chinese medicine composition of a kind of invigorating brain and relieving mental uneasiness and preparation method thereof
CN102772748B (en) Traditional Chinese medicine preparation for treating liver-depression qi-stagnation type viral myocarditis and preparation method thereof
CN101637579A (en) Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof
CN104208302A (en) Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof
CN101524469B (en) Chinese herbal medicine compound preparation for treating congestive heart failure and preparation method thereof
CN104905267A (en) Semen cassiae health oral liquid capable of decreasing blood lipid and preparation method thereof
CN101199672A (en) Chinese medicine health care wine containing function of regulating human body immunity
CN105456710B (en) A kind of blood activating and fat reducing medicine and preparation method thereof
CN105194421A (en) Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof
CN102631538B (en) Traditional Chinese medicine for treating heart disease
CN101549046A (en) Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma
CN101095798B (en) Chinese traditional medicine for treating canities
CN105687788A (en) Pharmaceutical composition capable of softening blood vessels and application thereof
CN105012873A (en) Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof
CN101313994A (en) Traditional Chinese medicine capsule for treating auricular fibrillation
CN103725587A (en) Sealwort and hawthorn vinegar and production method thereof
CN103877325A (en) Traditional Chinese medicine composition for treating heart-cerebral vascular disease and preparation method thereof
CN103536849A (en) Drug for treating pulmonary embolism and preparation method thereof
CN106334065A (en) Edible and medicinal traditional Chinese medicine formula used for treating gynecological diseases and having beauty effect and production process
CN104758676A (en) Medicine for treating damp-heat in resistance-type epigastric pain
CN108853340A (en) A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof
CN104352717A (en) Traditional Chinese medicine preparation for treating spleen-qi weakness type hemafecia and preparation method thereof
CN104799276B (en) Panax notoginseng and gastrodia elata powder for promoting normal circulation of blood and thrombolysis, and preparation method thereof
CN107929524A (en) A kind of coltsfoot frondosa oral liquid of lowering blood-fat and reducing weight and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171121

Termination date: 20220107

CF01 Termination of patent right due to non-payment of annual fee